---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-21-000928"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2021-07-27T23:59:59+00:00"
generated_at: "2026-06-30T02:24:46.070373+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# USANA posts record Q2 sales of $336.8M (+30.1% YoY); EPS $1.87 (+41.7% YoY)

## Summary
- Q2 net sales $336.8M, +30.1% YoY; diluted EPS $1.87, +41.7% YoY; active customers 652K (+8.8%).
- Asia Pacific sales $279M (+33.3% YoY); Americas & Europe $57.9M (+16.5% YoY).
- Gross margin improved 150bps to 83.1%; associate incentives rose 290bps to 45.7% of sales.
- Repurchased 304K shares for $29.7M in Q2; $51M remaining under authorization.
- FY2021 outlook reiterated: net sales $1.24-$1.28B, diluted EPS $6.15-$6.50.

## SEC filing metadata
- accession: 0001157523-21-000928
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2021-07-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752321000928/0001157523-21-000928-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752321000928/a52466918.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-21-000928
- JSON: https://secwatch.observer/filing/0001157523-21-000928.json
- Plain text: https://secwatch.observer/filing/0001157523-21-000928.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.